The drugmaker cited solid sales growth and productivity gains, even as recent clinical-trial setbacks hit its bottom line in the third quarter.
Source link
Novartis Raises Guidance Despite Drug-Trial Setbacks Hitting Profit
Date:
More like thisRelated
TikTok parent ByteDance’s founder Zhang Yiming reclaims spot as China’s richest person, thanks to firm’s AI push
Beijing — ByteDance founder Zhang...
Mercedes-Benz Cuts Guidance on China Weakness, Higher Costs
Shares fell more than 5% after the automaker trimmed...
Transfer rumors, news: Real Madrid eye Liverpool’s Alexis Mac Allister
Oct 27, 2026, 04:38 AM ETLiverpool midfielder Alexis Mac...
Chester's Pick 6: The Top 6 plays or Players from the week
ALBUQUERQUE, N.M. (KRQE) – In this week's edition of...